Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis

G. Giacalone, F. Clarelli, A. M. Osiceanu, C. Guaschino, P. Brambilla, M. Sorosina, G. Liberatore, A. Zauli, F. Esposito, M. Rodegher, A. Ghezzi, D. Galimberti, F. Patti, N. Barizzone, F. Guerini, V. Martinelli, M. Leone, G. Comi, S. D'Alfonso, F. Martinelli Boneschi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The role of genetic factors in influencing the clinical expression of multiple sclerosis (MS) is unclear. Objective: The objective of this paper is to identify genes, pathways and networks implicated in age at onset (AAO) and severity, measured using the Multiple Sclerosis Severity Score (MSSS), of primary-progressive MS (PPMS). Methods: We conducted a genome-wide association study (GWAS) of 470 PPMS patients of Italian origin:. Allelic association of 296,589 SNPs with AAO and MSSS was calculated. Pathway and network analyses were also conducted using different tools. Results: No single association signal exceeded genome-wide significance in AAO and MSSS analyses. Nominally associated genes to AAO and MSSS were enriched in both traits for 10 pathways, including: "oxidative phosphorylation" (FDRAAO=9∗10-4; FDRMSSS=3.0∗10-2), "citrate (TCA) cycle" (FDRAAO=1.6∗10-2; FDRMSSS=3.2∗10-3), and "B cell receptor signaling" (FDRAAO=3.1∗10-2; FDRMSSS=2.2∗10-3). In addition, an enrichment of "chemokine signaling pathway" (FDR=9∗10-4) for AAO and of "leukocyte transendothelial migration" (FDR=2.4∗10-3) for MSSS trait was observed, among others. Network analysis revealed that p53 and CREB1 were central hubs for AAO and MSSS traits, respectively. Conclusions: Despite the fact that no major effect signals emerged in the present GWAS, our data suggest that genetic variants acting in the context of oxidative stress and immune dysfunction could modulate the onset and severity of PPMS.

Original languageEnglish
Pages (from-to)1431-1442
Number of pages12
JournalMultiple Sclerosis Journal
Volume21
Issue number11
DOIs
Publication statusPublished - 2015

Fingerprint

Chronic Progressive Multiple Sclerosis
Gene Regulatory Networks
Age of Onset
Multiple Sclerosis
Genome-Wide Association Study
Transendothelial and Transepithelial Migration
Oxidative Phosphorylation
Chemokines
Citric Acid
Single Nucleotide Polymorphism
Oxidative Stress
Leukocytes
B-Lymphocytes
Genome

Keywords

  • Age at onset
  • GWAS
  • Multiple sclerosis
  • Network analysis
  • Pathway analysis
  • Primary-progressive
  • Severity

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Giacalone, G., Clarelli, F., Osiceanu, A. M., Guaschino, C., Brambilla, P., Sorosina, M., ... Martinelli Boneschi, F. (2015). Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis. Multiple Sclerosis Journal, 21(11), 1431-1442. https://doi.org/10.1177/1352458514564590

Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis. / Giacalone, G.; Clarelli, F.; Osiceanu, A. M.; Guaschino, C.; Brambilla, P.; Sorosina, M.; Liberatore, G.; Zauli, A.; Esposito, F.; Rodegher, M.; Ghezzi, A.; Galimberti, D.; Patti, F.; Barizzone, N.; Guerini, F.; Martinelli, V.; Leone, M.; Comi, G.; D'Alfonso, S.; Martinelli Boneschi, F.

In: Multiple Sclerosis Journal, Vol. 21, No. 11, 2015, p. 1431-1442.

Research output: Contribution to journalArticle

Giacalone, G, Clarelli, F, Osiceanu, AM, Guaschino, C, Brambilla, P, Sorosina, M, Liberatore, G, Zauli, A, Esposito, F, Rodegher, M, Ghezzi, A, Galimberti, D, Patti, F, Barizzone, N, Guerini, F, Martinelli, V, Leone, M, Comi, G, D'Alfonso, S & Martinelli Boneschi, F 2015, 'Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis', Multiple Sclerosis Journal, vol. 21, no. 11, pp. 1431-1442. https://doi.org/10.1177/1352458514564590
Giacalone, G. ; Clarelli, F. ; Osiceanu, A. M. ; Guaschino, C. ; Brambilla, P. ; Sorosina, M. ; Liberatore, G. ; Zauli, A. ; Esposito, F. ; Rodegher, M. ; Ghezzi, A. ; Galimberti, D. ; Patti, F. ; Barizzone, N. ; Guerini, F. ; Martinelli, V. ; Leone, M. ; Comi, G. ; D'Alfonso, S. ; Martinelli Boneschi, F. / Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis. In: Multiple Sclerosis Journal. 2015 ; Vol. 21, No. 11. pp. 1431-1442.
@article{5dacaef1f6044d15885d1fe0fd29f883,
title = "Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis",
abstract = "Background: The role of genetic factors in influencing the clinical expression of multiple sclerosis (MS) is unclear. Objective: The objective of this paper is to identify genes, pathways and networks implicated in age at onset (AAO) and severity, measured using the Multiple Sclerosis Severity Score (MSSS), of primary-progressive MS (PPMS). Methods: We conducted a genome-wide association study (GWAS) of 470 PPMS patients of Italian origin:. Allelic association of 296,589 SNPs with AAO and MSSS was calculated. Pathway and network analyses were also conducted using different tools. Results: No single association signal exceeded genome-wide significance in AAO and MSSS analyses. Nominally associated genes to AAO and MSSS were enriched in both traits for 10 pathways, including: {"}oxidative phosphorylation{"} (FDRAAO=9∗10-4; FDRMSSS=3.0∗10-2), {"}citrate (TCA) cycle{"} (FDRAAO=1.6∗10-2; FDRMSSS=3.2∗10-3), and {"}B cell receptor signaling{"} (FDRAAO=3.1∗10-2; FDRMSSS=2.2∗10-3). In addition, an enrichment of {"}chemokine signaling pathway{"} (FDR=9∗10-4) for AAO and of {"}leukocyte transendothelial migration{"} (FDR=2.4∗10-3) for MSSS trait was observed, among others. Network analysis revealed that p53 and CREB1 were central hubs for AAO and MSSS traits, respectively. Conclusions: Despite the fact that no major effect signals emerged in the present GWAS, our data suggest that genetic variants acting in the context of oxidative stress and immune dysfunction could modulate the onset and severity of PPMS.",
keywords = "Age at onset, GWAS, Multiple sclerosis, Network analysis, Pathway analysis, Primary-progressive, Severity",
author = "G. Giacalone and F. Clarelli and Osiceanu, {A. M.} and C. Guaschino and P. Brambilla and M. Sorosina and G. Liberatore and A. Zauli and F. Esposito and M. Rodegher and A. Ghezzi and D. Galimberti and F. Patti and N. Barizzone and F. Guerini and V. Martinelli and M. Leone and G. Comi and S. D'Alfonso and {Martinelli Boneschi}, F.",
year = "2015",
doi = "10.1177/1352458514564590",
language = "English",
volume = "21",
pages = "1431--1442",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis

AU - Giacalone, G.

AU - Clarelli, F.

AU - Osiceanu, A. M.

AU - Guaschino, C.

AU - Brambilla, P.

AU - Sorosina, M.

AU - Liberatore, G.

AU - Zauli, A.

AU - Esposito, F.

AU - Rodegher, M.

AU - Ghezzi, A.

AU - Galimberti, D.

AU - Patti, F.

AU - Barizzone, N.

AU - Guerini, F.

AU - Martinelli, V.

AU - Leone, M.

AU - Comi, G.

AU - D'Alfonso, S.

AU - Martinelli Boneschi, F.

PY - 2015

Y1 - 2015

N2 - Background: The role of genetic factors in influencing the clinical expression of multiple sclerosis (MS) is unclear. Objective: The objective of this paper is to identify genes, pathways and networks implicated in age at onset (AAO) and severity, measured using the Multiple Sclerosis Severity Score (MSSS), of primary-progressive MS (PPMS). Methods: We conducted a genome-wide association study (GWAS) of 470 PPMS patients of Italian origin:. Allelic association of 296,589 SNPs with AAO and MSSS was calculated. Pathway and network analyses were also conducted using different tools. Results: No single association signal exceeded genome-wide significance in AAO and MSSS analyses. Nominally associated genes to AAO and MSSS were enriched in both traits for 10 pathways, including: "oxidative phosphorylation" (FDRAAO=9∗10-4; FDRMSSS=3.0∗10-2), "citrate (TCA) cycle" (FDRAAO=1.6∗10-2; FDRMSSS=3.2∗10-3), and "B cell receptor signaling" (FDRAAO=3.1∗10-2; FDRMSSS=2.2∗10-3). In addition, an enrichment of "chemokine signaling pathway" (FDR=9∗10-4) for AAO and of "leukocyte transendothelial migration" (FDR=2.4∗10-3) for MSSS trait was observed, among others. Network analysis revealed that p53 and CREB1 were central hubs for AAO and MSSS traits, respectively. Conclusions: Despite the fact that no major effect signals emerged in the present GWAS, our data suggest that genetic variants acting in the context of oxidative stress and immune dysfunction could modulate the onset and severity of PPMS.

AB - Background: The role of genetic factors in influencing the clinical expression of multiple sclerosis (MS) is unclear. Objective: The objective of this paper is to identify genes, pathways and networks implicated in age at onset (AAO) and severity, measured using the Multiple Sclerosis Severity Score (MSSS), of primary-progressive MS (PPMS). Methods: We conducted a genome-wide association study (GWAS) of 470 PPMS patients of Italian origin:. Allelic association of 296,589 SNPs with AAO and MSSS was calculated. Pathway and network analyses were also conducted using different tools. Results: No single association signal exceeded genome-wide significance in AAO and MSSS analyses. Nominally associated genes to AAO and MSSS were enriched in both traits for 10 pathways, including: "oxidative phosphorylation" (FDRAAO=9∗10-4; FDRMSSS=3.0∗10-2), "citrate (TCA) cycle" (FDRAAO=1.6∗10-2; FDRMSSS=3.2∗10-3), and "B cell receptor signaling" (FDRAAO=3.1∗10-2; FDRMSSS=2.2∗10-3). In addition, an enrichment of "chemokine signaling pathway" (FDR=9∗10-4) for AAO and of "leukocyte transendothelial migration" (FDR=2.4∗10-3) for MSSS trait was observed, among others. Network analysis revealed that p53 and CREB1 were central hubs for AAO and MSSS traits, respectively. Conclusions: Despite the fact that no major effect signals emerged in the present GWAS, our data suggest that genetic variants acting in the context of oxidative stress and immune dysfunction could modulate the onset and severity of PPMS.

KW - Age at onset

KW - GWAS

KW - Multiple sclerosis

KW - Network analysis

KW - Pathway analysis

KW - Primary-progressive

KW - Severity

UR - http://www.scopus.com/inward/record.url?scp=84985972782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985972782&partnerID=8YFLogxK

U2 - 10.1177/1352458514564590

DO - 10.1177/1352458514564590

M3 - Article

VL - 21

SP - 1431

EP - 1442

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 11

ER -